€4.90 low for MLBON.PA bonyf N.V. EURONEXT 21 Jan 2026: Oversold bounce trade idea
MLBON.PA stock trades at €4.90 intraday on EURONEXT on 21 Jan 2026, sitting at the year low and showing signs of an oversold bounce setup. Volume is extremely light at 2 shares today versus an average volume of 3, which raises execution risk even as the price sits well below the 50-day average (€9.86) and 200-day average (€12.99). For short-term traders we see a potential technical bounce play, but low liquidity and negative EPS (-1.77) demand strict risk controls and tight sizing.
MLBON.PA stock: Intraday price, volume and immediate risk
The stock is quoted at €4.90 with day low and high both at €4.90, reflecting near-zero intraday trade activity. Market cap stands at €2,884,140.00 and shares outstanding are 588,600. One immediate risk is liquidity: today’s volume of 2 against an avg volume of 3 makes stop execution and price discovery unreliable.
MLBON.PA stock: Why we view this as an oversold bounce setup
Price has collapsed from a year high of €19.50 to the current €4.90, a decline of 72.78% over 12 months and 62.02% over one month. Such a drawdown places MLBON.PA well below moving averages, which can trigger short-term mean reversion bounces when order flow returns. The technicals show a negative MACD (-0.32) and ADX at 100.00, signalling a strong trend but with momentum stretched and ripe for a corrective bounce.
MLBON.PA stock: Fundamentals, valuation and sector context
bonyf N.V. operates in Healthcare (Medical – Instruments & Supplies) with EPS -1.77 and a trailing PE of -2.77. Book value per share is €4.49, giving a price-to-book of 1.09 versus the Healthcare sector average PB around 2.06, indicating the stock trades at a discount to sector peers on book value. Operating cash flow per share is unusually large in the data set at 96.76, but working capital challenges and long receivable days (DSO 409.75) are real operational flags.
MLBON.PA stock: Technicals and trade plan for an oversold bounce
Short-term technicals favour a cautious long-leaning trade on a confirmed reversal. A practical plan: wait for a two-bar reversal or intraday volume pick-up above 10 shares, set a tight stop below €4.80, and a first profit target at €7.50 (near half the 50-day gap). Use micro position sizing given the low liquidity and aim to exit if price fails to sustain a move above €6.00.
MLBON.PA stock: Catalysts, risks and sector comparison
Catalysts for a sustained recovery would include improved liquidity, a clear earnings or commercial update from bonyf N.V., or broader Healthcare sector strength. Major risks are illiquidity, negative margins (net margin -12.97%), and receivables turnover under 1.0. By comparison, Healthcare peers typically trade at higher PB and PE multiples, so any positive corporate news could produce outsized relative moves.
MLBON.PA stock: Meyka AI grade and analyst framing
Meyka AI rates MLBON.PA with a score out of 100: 61.42 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade reflects a mix of cheap book value, weak profitability and low liquidity. These grades are model outputs, not guarantees, and are not financial advice.
Final Thoughts
Key takeaways for MLBON.PA stock: the intraday price of €4.90 on EURONEXT on 21 Jan 2026 marks the year low and a classic oversold environment that can produce short-term bounces. Liquidity is the dominant constraint — today’s volume of 2 shares makes market entries and exits risky, so traders must use micro sizing and strict stops. Valuation shows a price-to-book of 1.09 and a negative EPS (-1.77), while sector PB averages are higher, leaving upside on a recovery but with significant fundamental uncertainty. Meyka AI’s forecast model projects a yearly path to €11.78, implying an upside of 140.82% versus the current €4.90. Forecasts are model-based projections and not guarantees. For intraday oversold bounce trades we recommend confirmation by volume above 10 shares and a staged target plan, while longer-term investors should watch operating cash flow dynamics and receivables improvement before increasing exposure. For the latest market moves and order-flow alerts see the bonyf overview on Meyka AI MLBON.PA stock page and recent market coverage source.
FAQs
Is MLBON.PA stock a buy after the intraday drop?
MLBON.PA stock at €4.90 shows a possible short-term oversold bounce, but low liquidity and negative EPS make it a tactical trade rather than a clear buy. Use small position sizes and volume-confirmed entry.
What is Meyka AI’s forecast for MLBON.PA stock?
Meyka AI’s forecast model projects a 1-year target of €11.78, implying 140.82% upside versus €4.90. Forecasts are model-based projections and not guarantees.
What are the main risks when trading MLBON.PA stock intraday?
Primary risks are extremely low liquidity (today’s volume 2), wide spreads, negative profitability, and long receivable days. Stops can fail when volumes stay below average.
How does MLBON.PA stock compare to the Healthcare sector?
MLBON.PA trades at PB 1.09 versus Healthcare average PB 2.06, showing a book-value discount but weaker margins and higher operational risk compared with sector peers.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
